Sector: Health Care
Director information for HUMANA INC
Board as disclosed in the proxy statement filed March 6, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| David T. Feinberg, M.D. | Director; Chairman of Oracle Health | 63 | ["Former Director, President and CEO at Cerner Corporation","Public Company CEO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Healthcare Industry Experience","IT/Digital; Data Privacy; Cyber Experience","Marketing/Consumer Insights","Risk Assessment","Corporate Governance","Sustainability/ESG"] | ["Clinical Quality Committee (Chair)","Nominating, Governance & Sustainability Committee"] | 2026 |
| Frank A. D’Amelio | Former Executive Vice President, CFO at Pfizer Inc.; Independent Director | 68 | ["Public Company CFO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Healthcare Industry Experience","Government Relations/Public Policy","Risk Assessment","Corporate Governance","Sustainability/ESG"] | ["Audit Committee (Chair)","Nominating, Governance & Sustainability Committee"] | 2026 |
| Gordon Smith | Director; Former Co-President and Co-COO at JPMorgan Chase & Co. | 67 | ["Public Company COO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","IT/Digital; Data Privacy; Cyber Experience","Marketing/Consumer Insights","Risk Assessment","Corporate Governance"] | ["Organization & Compensation Committee (Chair)","Technology Committee"] | 2026 |
| James A. Rechtin | Director; President & Chief Executive Officer, Humana Inc.; President & CEO | 55 | ["Former President & CEO at Envision Healthcare","CEO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Healthcare Industry Experience","Marketing/Consumer Insights","Risk Assessment","Corporate Governance"] | [] | 2026 |
| Jorge S. Mesquita | Director; Former CEO at Blue Triton Brands | 64 | ["Former Executive Vice President, Worldwide Chairman, Consumer at Johnson & Johnson","Healthcare Industry Experience","Marketing/Consumer Insights","Sustainability/ESG","Former Chief Executive Officer Blue Triton Brands","Former Executive Vice President, Worldwide Chairman, Consumer Johnson & Johnson","29 years at Procter & Gamble"] | ["Investment Committee","Clinical Quality Committee"] | 2026 |
| Karen W. Katz | Director; Former President & CEO at Neiman Marcus Group LTD LCC | 69 | ["Public Company CEO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Marketing/Consumer Insights","Risk Assessment","Corporate Governance"] | ["Nominating, Governance & Sustainability Committee (Chair)","Organization & Compensation Committee"] | 2026 |
| Kurt J. Hilzinger | Executive Advisor, Former Partner, Court Square Capital Partners; Chairman of the Board, Director | 65 | ["Former Director, President and COO at AmerisourceBergen Corporation","Public Company COO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Healthcare Industry Experience","Government Relations/Public Policy","Risk Assessment","Corporate Governance"] | ["Investment Committee"] | 2026 |
| Marcy S. Klevorn | Director; Former Chief Transformation Officer at Ford Motor Company | 66 | ["Financial Oversight","Capital Allocation and Corporate Transactions","IT/Digital; Data Privacy; Cyber Experience","Marketing/Consumer Insights","Risk Assessment","Corporate Governance","Sustainability/ESG","Former Chief Transformation Officer at Ford Motor Company","Joined Ford Motor Company in 1983","Key executive roles in information technology","Executive Vice President and President of Ford Smart Mobility LLC"] | ["Technology Committee (Chair)","Audit Committee"] | 2026 |
| Raquel C. Bono, M.D. | Director | 69 | ["CEO Experience","Financial Oversight, Capital Allocation and Corporate Transactions","Healthcare Industry Experience","Government Relations/Public Policy","Risk Assessment","Sustainability/ESG"] | ["Audit Committee","Clinical Quality Committee"] | 2026 |
| Sanjay K. Shetty, M.D. | President, CenterWell | [] | [] | 2026 | |
| Susan M. Diamond | Former Chief Financial Officer | 52 | [] | [] | 2026 |
| Wayne A. I. Frederick, M.D. | Interim President and President Emeritus at Howard University; Director | 54 | ["Healthcare Industry Experience","Government Relations/Public Policy","Sustainability/ESG"] | ["Organization & Compensation Committee","Technology Committee"] | 2026 |
